Correct Answer: C

Rationale: Providing information on safety aligns with the TTM framework.

Correct Answer: D

Rationale: The best strategy for the nurse to use when teaching insulin injection techniques to a newly diagnosed client with diabetes is to observe a return demonstration. This method ensures that the client can correctly perform the technique. Providing written pre and post tests (choice A) may assess knowledge but not application. Asking questions during practice (choice B) may help with understanding but not necessarily with the actual performance. Allowing another diabetic to assist (choice C) may provide peer support but does not guarantee correct technique demonstration.

Correct Answer: C

Rationale: The correct answer is C: Bradycardia. Digoxin toxicity often presents with bradycardia, which is a common sign of toxicity associated with this medication. Tachycardia (Choice A) is not typically seen with digoxin toxicity. Hypotension (Choice B) can occur but is less specific to digoxin toxicity. Hyperglycemia (Choice D) is not a typical sign of digoxin toxicity. Therefore, monitoring for bradycardia is crucial in clients receiving digoxin to detect toxicity early.

Correct Answer: A

Rationale: The correct answer is A: 'Double the birth weight.' Infants typically double their birth weight by 6 months of age. This is a common milestone in healthy infant growth and development. Choice B is incorrect because tripling the birth weight would be excessive and not in line with normal growth patterns. Choice C, 'Gain 6 ounces each week,' is not accurate as infant growth is not linear each week. Choice D, 'Add 2 pounds each month,' is also incorrect as this rate of growth would be too rapid and unrealistic for healthy infant development.

Correct Answer: A

Rationale: The correct answer is A: Hypertension. Erythropoietin can lead to hypertension as a side effect due to its stimulation of red blood cell production, which can increase blood viscosity. This can result in elevated blood pressure. Choices B, C, and D are incorrect. Hypoglycemia is not a common side effect of erythropoietin. Hyperkalemia is more commonly associated with renal failure rather than erythropoietin use. Hypocalcemia is not a typical side effect of erythropoietin administration.